Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

ABSTRACT Between 0.3%–4.6% of women use antipsychotic (AP) drugs during pregnancy.
Two large, retrospective, population-based cohort studies, conducted in Nordic countries …

Background Antipsychotics are commonly prescribed to treat a range of psychiatric
conditions in women of reproductive age and during pregnancy, including schizophrenia …

The paucity of evidence regarding the safety of gestational antipsychotic exposure has led to
treatment discontinuation in pregnant women with severe mental health conditions. This …

Aim To compare the prevalence and trends of antipsychotic drug use during pregnancy
between countries across four continents. Methods Individually linked health data in …

Objective To investigate the admission rate to neonatal care and neonatal morbidity after
maternal use of antipsychotics during pregnancy. Design A population-based register study …

Objective To evaluate maternal medical and perinatal outcomes associated with
antipsychotic drug use in pregnancy. Design High dimensional propensity score (HDPS) …

Objective To investigate whether in utero exposure to antidepressants is associated with
increased risk of attention deficit hyperactivity disorder (ADHD). Design Cohort study. Setting …

Objective: To identify distinct trajectories of antipsychotic use prior to and during pregnancy
and describe the associated maternal and birth characteristics. Methods: We conducted a …

Background Limited information is available on whether antipsychotics prescribed in
pregnancy are associated with increased risks of adverse outcomes. Methods We used …